Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2012
10/30/2012CA2565293C Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
10/26/2012WO2012145569A1 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
10/26/2012WO2012144661A1 Aromatic heterocyclic derivative having trpv4-inhibiting activity
10/26/2012WO2012144654A1 Fluorescent probe for measuring hydrogen sulfide
10/26/2012WO2012144562A1 Deprotection method for protected hydroxyl group
10/26/2012WO2012143399A1 Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines
10/26/2012WO2012143317A1 Novel pesticidal pyrazole compounds
10/26/2012WO2012119046A3 Heterocyclic compounds for the inhibition of pask
10/26/2012CA2833288A1 Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines
10/26/2012CA2832955A1 Deprotection method for protected hydroxyl group
10/26/2012CA2830138A1 Novel pesticidal pyrazole compounds
10/26/2012CA2829264A1 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
10/25/2012US20120270904 Co-crystal of 4-furan-2(5h)-one with oxalic acid and use thereof as pesticide
10/25/2012US20120270869 Pyridyl derivatives as cftr modulators
10/25/2012US20120270865 Heterocyclic compound
10/25/2012US20120270858 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
10/25/2012US20120270852 Phenyl or pyridinyl-ethynyl derivatives
10/25/2012US20120270847 Novel carbamate amino acid and peptide prodrugs of opiates and uses thereof
10/25/2012US20120269766 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
10/24/2012EP2514748A1 2,4-diaminoquinazolines for spinal muscular atrophy
10/24/2012EP2513093A1 New ccr2 receptor antagonists and uses thereof
10/24/2012EP2513092A1 Heterocyclic antiviral compounds
10/24/2012EP2513091A1 Hepatitis c virus inhibitors
10/24/2012EP2513086A1 Novel antagonists for ccr2 and uses thereof
10/24/2012EP2513084A1 Pyrrolidine derivatives as nk - 3 receptor antagonists
10/24/2012EP2513065A1 Process for the preparation of key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
10/24/2012EP2513064A2 Compounds, compositions and methods for controlling biofilms
10/24/2012EP2513054A1 Bicyclic derivatives useful as inhibitors of dpp-1
10/24/2012EP2513053A1 Pyrrolidine or thiazolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disordersas as agonists of g- protein coupled receptor 43 (gpr43)
10/24/2012EP2513052A1 Pyrrolidine derivatives
10/24/2012EP2512243A1 Quinoline amide m1 receptor positive allosteric modulators
10/24/2012CN102753540A A4ss2 neuronal nicotinic acetylcholine receptor ligands
10/24/2012CN102753534A Process for the preparation of key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
10/24/2012CN102753527A Cyclohexyl amide derivatives as crf receptor antagonists
10/24/2012CN102753524A Bicyclic derivatives useful as inhibitors of dpp-1
10/24/2012CN102753172A 5-HT4 receptor agonists for the treatment of dementia
10/24/2012CN102746282A N-5-substituted phenyl-2-furoyl compounds, preparation method and application thereof
10/24/2012CN102746281A 4-1,2,3-triazole-coumarin derivative and its preparation method and application
10/24/2012CN102212065B Isonucleoside compound or ortho-phosphite derivative thereof and preparation method and application thereof
10/24/2012CN102050807B 3-aryl-4-(2-acyloxy ethyoxyl)-2(5H)-furanone compound and preparation method and application thereof
10/24/2012CN101827839B 1,3,5-trisubstituted triazole derivative
10/24/2012CN101668524B Pyrazole derivatives as 11-beta-hsd1 inhibitors
10/24/2012CN101567425B Organic electroluminescence device, novel platinum complex compound and novel compound capable of being a ligand thereof
10/23/2012US8293929 Processes and intermediates
10/23/2012US8293895 Carbapenem derivatives
10/23/2012US8293751 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/23/2012US8293747 Heterocyclic amide compounds as protein kinase inhibitors
10/23/2012US8293732 Antibacterial quinoline derivatives
10/23/2012CA2689659C Nitrogen-containing heterocyclic derivative having 11.beta.-hydroxysteroid dehydrogenase type 1 inhibitory activity
10/23/2012CA2548058C Herbicidal pyrimidines
10/23/2012CA2547243C N-aryl piperidine substituted biphenylcarboxamides
10/23/2012CA2523178C Materials and methods to potentiate cancer treatment
10/23/2012CA2488635C Antagonists of melanin concentrating hormone receptor
10/23/2012CA2441410C Compounds and method of treatment having agonist-like activity selective at alpha 2b or 2b/2c adrenergic receptors
10/18/2012WO2012142504A1 Aryl-or heteroaryl-substituted benzene compounds
10/18/2012WO2012142459A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
10/18/2012WO2012141499A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
10/18/2012WO2012141228A1 Novel pyrazole derivative
10/18/2012WO2012140597A1 Glycoside derivatives and their uses for the treatment of diabetes
10/18/2012WO2012140243A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
10/18/2012WO2012140001A1 Use of substituted dithiine-dicarboximides for combating phytopathogenic fungi
10/18/2012WO2012113850A3 (PYRIDIN-4-YL)BENZYLAMIDES AS ALLOSTERIC MODULATORS OF ALPHA 7 nAChR
10/18/2012US20120264943 Compounds Suitable As Precursors to Compounds that are Useful for Imaging Amyloid Deposits
10/18/2012US20120264801 5-membered heterocycle-based p38 kinase inhibitors
10/18/2012US20120264761 Aminobenzoquinazolinone M1 Receptor Positive Allosteric Modulators
10/18/2012US20120264760 Compounds and Methods for Treating Mammalian Gastrointestinal Parasitic Infections
10/18/2012US20120264755 Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase
10/18/2012US20120264736 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
10/18/2012US20120264734 Aryl- or Heteroaryl-Substituted Benzene Compounds
10/18/2012US20120264733 Heterocyclic compound and use thereof
10/18/2012US20120263708 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
10/18/2012US20120263659 Use of physiological cooling active ingredients, and agents containing such active ingredients
10/18/2012US20120261650 Organic electroluminescent device
10/18/2012CA2832958A1 Glycoside derivatives and their use for the treatment of diabetes
10/18/2012CA2832843A1 Aryl-or heteroaryl-substituted benzene compounds
10/18/2012CA2832650A1 Novel pyrazole derivative
10/18/2012CA2832505A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
10/17/2012EP2511273A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
10/17/2012EP2511271A1 Heteroarylcarboxylic acid ester derivative
10/17/2012EP2511267A1 3-((n-acylated aminoacyl)amino)pyrazoles as inhibitors of beta-amyloid peptide production useful for the treatment of alzheimer's disease
10/17/2012EP2511255A1 Substituted prop-2-in-1-ol and prop-2-en-1-ol derivatives
10/17/2012EP2509958A1 Azole derivatives, methods for producing the same, intermediate thereof, agro-horticultural agents
10/17/2012EP2509957A1 Cysteine protease inhibitors
10/17/2012EP2509956A1 Cysteine protease inhibitors
10/17/2012EP2509954A1 4 -oxo- 1h -quinoline- 3 - carboxamides as modulators of atp -binding cassette transporters
10/17/2012EP2509950A1 5-amino- 4-hydroxypentoyl amides
10/17/2012EP2509600A1 Therapeutically active compounds for use in the treatment of cancer characterized as having an idh mutation
10/17/2012CN102741263A Process for preparation of beta-glycoside compounds
10/17/2012CN102741244A Novel solid form of 4-[[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino]furan-2(5h)-one
10/17/2012CN102741243A Novel compound amycolatopsis derivative, and production process and use of same
10/17/2012CN102741242A Hepatitis c virus inhibitors
10/17/2012CN102741237A Beta-dihydrofuran deriving compound, method for producing beta-dihydrofuran deriving compound or beta-tetrahydrofuran deriving compound, beta-glycoside compound, method for producing beta-glycoside compound, and method for producing 4'-ethynyl d4t and analogue comp
10/17/2012CN102741226A 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
10/17/2012CN102731485A 4-(substituted phenylamino)quinazoline derivative, its preparation method, pharmaceutical composition and application
10/17/2012CN102731455A Carabrone derivatives having bactericidal activities, and use thereof
10/17/2012CN102731454A Dehydrocostunolide derivative, its pharmaceutical composition, preparation method and application thereof
10/17/2012CN102731416A 1-(aryl methyl)-quinazoline-2,4-dione as PARP inhibitor and its application
10/17/2012CN101939297B Benzylpiperizine compound
10/17/2012CN101914084B Derivative of diphenylpyrone nitrogen heterocyclic ring as well as preparation method and application thereof
10/17/2012CN101370772B Diketooxime ester compound and use thereof
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 694